Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06459934
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-06-11
Brief Title:
Clinical Outcomes of Cardiovascular Disease
Sponsor:
Xinjiang Medical University
Organization:
Xinjiang Medical University
Study Overview
Official Title:
Clinical Outcomes of Cardiovascular Disease a Prospective Cohort Study
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CLEAR
Brief Summary:
This study is a prospective single center cohort study that primarily registers the clinical characteristics outcomes and influencing factors of patients with different types of cardiovascular diseases Evaluate multiple examination indicators of patients at baseline 1 year and longer and follow up on the incidence of major cardiovascular and cerebrovascular adverse events heart failure readmission death and other endpoint events
Detailed Description:
This study is a prospective single center cohort study that primarily registers the clinical characteristics outcomes and influencing factors of patients with different types of cardiovascular diseases Mainly including coronary heart disease cardiomyopathy hypertension heart failure and other diseases multiple examination indicators are evaluated for patients at baseline 1 year and longer periods of time The primary endpoints for coronary heart disease are all-cause mortality cardiogenic death non fatal myocardial infarction hospitalization for heart failure and major cardiovascular adverse events The primary endpoints for cardiomyopathy are all-cause mortality cardiogenic death hospitalization for heart failure and major cardiovascular adverse events The primary endpoints for hypertension are stroke all-cause mortality cardiogenic death hospitalization for heart failure and major cardiovascular and cerebrovascular adverse events The primary endpoints for heart failure are all-cause mortality cardiogenic death readmission for heart failure and major cardiovascular adverse events
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None